GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (NZSE:FPH) » Definitions » Debt-to-Asset

Fisher & Paykel Healthcare (NZSE:FPH) Debt-to-Asset : 0.14 (As of Sep. 2023)


View and export this data going back to 1979. Start your Free Trial

What is Fisher & Paykel Healthcare Debt-to-Asset?

Fisher & Paykel Healthcare's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was NZ$24 Mil. Fisher & Paykel Healthcare's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was NZ$300 Mil. Fisher & Paykel Healthcare's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2023 was NZ$2,390 Mil. Fisher & Paykel Healthcare's debt to asset for the quarter that ended in Sep. 2023 was 0.14.


Fisher & Paykel Healthcare Debt-to-Asset Historical Data

The historical data trend for Fisher & Paykel Healthcare's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fisher & Paykel Healthcare Debt-to-Asset Chart

Fisher & Paykel Healthcare Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 0.10 0.06 0.05 0.07

Fisher & Paykel Healthcare Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.05 0.05 0.07 0.14

Competitive Comparison of Fisher & Paykel Healthcare's Debt-to-Asset

For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fisher & Paykel Healthcare's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Fisher & Paykel Healthcare's Debt-to-Asset falls into.



Fisher & Paykel Healthcare Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Fisher & Paykel Healthcare's Debt-to-Asset for the fiscal year that ended in Mar. 2023 is calculated as

Fisher & Paykel Healthcare's Debt-to-Asset for the quarter that ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fisher & Paykel Healthcare  (NZSE:FPH) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Fisher & Paykel Healthcare Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Fisher & Paykel Healthcare (NZSE:FPH) Business Description

Traded in Other Exchanges
Address
15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnoea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the U.S., 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.